Bridging the gap: how do we enroll more racial-ethnic minority patients in hematological drug trials?

被引：1
作者：
Espinoza-Gutarra, Manuel R. [1 ]
Ailawadhi, Sikander [2 ,3 ]
机构：
[1] Univ Alabama Birmingham, Div Hematol Oncol, Birmingham, AL USA
[2] Mayo Clin, Div Hematol Oncol, Jacksonville, FL USA
[3] 4500 San Pablo Rd, Jacksonville, FL 32224 USA
来源：
EXPERT REVIEW OF HEMATOLOGY | 2023年 / 16卷 / 12期
关键词：
Clinical trials; disparity; race; ethnicity; hematological malignancies; HEMATOPOIETIC-CELL TRANSPLANTATION; BONE-MARROW-TRANSPLANTATION; CANCER CLINICAL-TRIALS; MULTIPLE-MYELOMA; AFRICAN-AMERICAN; SOCIOECONOMIC DISPARITIES; MYELODYSPLASTIC SYNDROME; HODGKINS LYMPHOMA; UNITED-STATES; PARTICIPATION;
D O I：
10.1080/17474086.2023.2273851
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：905 / 910
页数：6
相关论文
共 95 条
  • [1] Racial Disparities in Survival Among Non-Hodgkin Lymphoma Patients: An Analysis of the SEER Database (2007-2015)
    Abodunrin, Faith O.
    Akinyemi, Oluwasegun A.
    Ojo, Ademola S.
    Nasef, Kindha Elleissy
    Haupt, Thomas
    Oduwole, Ayobami
    Olanrewaju, Oni
    Akinwumi, Bolarinwa
    Fakorede, Mary
    Ogunbona, Oluwaseun
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (06)
  • [2] Structural racism is a mediator of disparities in acute myeloid leukemia outcomes
    Abraham, Ivy Elizabeth
    Rauscher, Garth H.
    Patel, Anand Ashwin
    Pearse, William B.
    Rajakumar, Priya
    Burkart, Madelyn
    Aleem, Ahmed
    Dave, Ami
    Bharadwaj, Sushma
    Paydary, Koosha
    Acevedo-Mendez, Maria
    Goparaju, Krishna
    Gomez, Richard
    Carlson, Kylie
    Tsai, Stephanie B.
    Quigley, John G.
    Galvin, John P.
    Zia, Maryam
    Larson, Melissa L.
    Berg, Stephanie
    Stock, Wendy
    Altman, Jessica K.
    Khan, Irum
    [J]. BLOOD, 2022, 139 (14) : 2212 - 2226
  • [3] Impact of race on outcomes in intermediate-risk acute myeloid leukemia
    Abraham, Ivy Elizabeth
    Patel, Anand Ashwin
    Wang, Heidy
    Galvin, John Patrick
    Frankfurt, Olga
    Liu, Li
    Khan, Irum
    [J]. CANCER CAUSES & CONTROL, 2021, 32 (07) : 705 - 712
  • [4] Racial/ethnic and socioeconomic disparities in survival among children with acute lymphoblastic leukemia in California, 1988-2011: A population-based observational study
    Abrahao, Renata
    Lichtensztajn, Daphne Y.
    Ribeiro, Raul C.
    Marina, Neyssa M.
    Keogh, Ruth H.
    Marcos-Gragera, Rafael
    Glaser, Sally L.
    Keegan, Theresa H. M.
    [J]. PEDIATRIC BLOOD & CANCER, 2015, 62 (10) : 1819 - 1825
  • [5] Racial Patterns of Peripheral T-Cell Lymphoma Incidence and Survival in the United States
    Adams, Scott V.
    Newcomb, Polly A.
    Shustov, Andrei R.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (09) : 963 - +
  • [6] Administration USFa D, FDAAA 801 FIN RUL
  • [7] Therapy Socioeconomic and Racial Disparity in Chimeric Antigen Receptor T Cell Therapy Access
    Ahmed, Nausheen
    Shahzad, Moazzam
    Shippey, Ernie
    Bansal, Rajat
    Mushtaq, Muhammad Umair
    Mahmoudjafari, Zahra
    Faisal, Muhammad Salman
    Hoffmann, Marc
    Abdallah, Al-Ola
    Divine, Clint
    Hamadani, Mehdi
    McGuirk, Joseph
    Shune, Leyla
    [J]. TRANSPLANTATION AND CELLULAR THERAPY, 2022, 28 (07): : 358 - 364
  • [8] Racial patterns of extranodal natural killer/T-cell lymphoma, nasal type, in California: a population-based study
    Ai, Weiyun Z.
    Chang, Ellen T.
    Fish, Kari
    Fu, Kai
    Weisenburger, Dennis D.
    Keegan, Theresa H. M.
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2012, 156 (05) : 626 - 632
  • [9] Disease and outcome disparities in multiple myeloma: exploring the role of race/ethnicity in the Cooperative Group clinical trials
    Ailawadhi, Sikander
    Jacobus, Susanna
    Sexton, Rachael
    Stewart, Alexander K.
    Dispenzieri, Angela
    Hussein, Mohamad A.
    Zonder, Jeffrey A.
    Crowley, John
    Hoering, Antje
    Barlogie, Bart
    Orlowski, Robert Z.
    Rajkumar, S. Vincent
    [J]. BLOOD CANCER JOURNAL, 2018, 8
  • [10] Enrollment of Black Participants in Pivotal Clinical Trials Supporting US Food and Drug Administration Approval of Chimeric Antigen Receptor-T Cell Therapy for Hematological Malignant Neoplasms
    Al Hadidi, Samer
    Schinke, Carolina
    Thanendrarajan, Sharmilan
    Zangari, Maurizio
    van Rhee, Frits
    [J]. JAMA NETWORK OPEN, 2022, 5 (04) : E228161
12345678910